Your browser doesn't support javascript.
loading
PINK1 is a target of T cell responses in Parkinson's disease.
Williams, Gregory P; Michaelis, Tanner; Lima-Junior, João Rodrigues; Frazier, April; Tran, Ngan K; Phillips, Elizabeth J; Mallal, Simon A; Litvan, Irene; Goldman, Jennifer G; Alcalay, Roy N; Sidney, John; Sulzer, David; Sette, Alessandro; Lindestam Arlehamn, Cecilia S.
Afiliación
  • Williams GP; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Michaelis T; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
  • Lima-Junior JR; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Frazier A; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Tran NK; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Phillips EJ; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
  • Mallal SA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
  • Litvan I; Department of Neurology, Columbia University, Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
  • Goldman JG; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
  • Alcalay RN; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Sidney J; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
  • Sulzer D; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Sette A; Department of Neuroscience, University of California San Diego, La Jolla, CA, USA.
  • Lindestam Arlehamn CS; JPG Enterprises LLC; prior: Shirley Ryan AbilityLab and Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
bioRxiv ; 2024 Feb 12.
Article en En | MEDLINE | ID: mdl-38405939
ABSTRACT
Parkinson's disease (PD) is associated with autoimmune T cells that recognize the protein alpha-synuclein in a subset of individuals. Multiple neuroantigens are targets of autoinflammatory T cells in classical central nervous system autoimmune diseases such as multiple sclerosis (MS). Here, we explored whether additional autoantigenic targets of T cells in PD. We generated 15-mer peptide pools spanning several PD-related proteins implicated in PD pathology, including GBA, SOD1, PINK1, parkin, OGDH, and LRRK2. Cytokine production (IFNγ, IL-5, IL-10) against these proteins was measured using a fluorospot assay and PBMCs from patients with PD and age-matched healthy controls. This approach identified unique epitopes and their HLA restriction from the mitochondrial-associated protein PINK1, a regulator of mitochondrial stability, as an autoantigen targeted by T cells. The T cell reactivity was predominantly found in male patients with PD, which may contribute to the heterogeneity of PD. Identifying and characterizing PINK1 and other autoinflammatory targets may lead to antigen-specific diagnostics, progression markers, and/or novel therapeutic strategies for PD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos